Physician profile
Michael L Arnold
NPI 1699105114
$8,194.26
in general payments reported to CMS, 2019-2025
15 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,522 · 2022: $416 · 2023: $30.70 · 2024: $97.28 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $5,865.29 | 2021-2022 | |
| Abbott Laboratories | $756.71 | 2021-2025 | Triclip |
| Biosense Webster, INC. | $273.87 | 2021-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $236.95 | 2021 | |
| Novartis Pharmaceuticals Corporation | $206.60 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $163.64 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $147.50 | 2022 | |
| Itamar Medical INC | $142.72 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $137.81 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $113.17 | 2021 | |
| Biotronik INC. | $60.46 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.99 | 2021 | |
| Boston Scientific Corporation | $19.67 | 2022 | |
| Chiesi USA, INC. | $19.02 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.